# SODIUM ACETATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2073986
Categories: food, industrial, pharma
Functions: Processing aids not otherwise specified
Identifier: DTXSID2073986

> SODIUM ACETATE is used as processing aids not otherwise specified. EPA CPDat observed this chemical in 22 composition records across product categories including Laboratory supplies, Food and drug. Assessed from 39 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 22 composition records across product categories including Laboratory supplies, Food and drug.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 22 composition records across product categories including Laboratory supplies, Food and drug. EPA CPDat classifies this chemical for functional uses including Processing aids not otherwise specified.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.02 %w/v
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Potency: 0.03 %w/w
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.68 %w/v
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: 0.03 %w/v
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION; Potency: 0.1 ml
- US: inactive ingredient database — Route: INTRADERMAL; Dosage form: INJECTION; Potency: 1.6 mg
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 19 mg
- US: inactive ingredient database — Route: INTRAOCULAR; Dosage form: SOLUTION; Maximum daily exposure: 195 mg
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 4239 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 141 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 328 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: LIQUID; Potency: 0.2 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: 0.39 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.08 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.24 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 0.1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 44 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 43 mg
- US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 12.5 mg
- US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 250 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 19 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.16 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: LIQUID; Potency: 0.2 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SOLUTION; Potency: 0.02 %w/v
- US: inactive ingredient database — Route: SUBMUCOSAL; Dosage form: INJECTION, SOLUTION; Potency: 0.08 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: NA
- US: marketed drug occurrence — FDA NDC lists this ingredient in 49 active drug products and 49 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._